Stockreport

Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants [Yahoo! Finance]

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today [Read more]